In what has implications for the US biosimilar sector, a federal judge has denied a request by sanofi-aventis for a preliminary injunction that would have directed the US Food and Drug Administration...
An Australian court has admitted a petition challenging the validity of a patent for a human gene (BRCA1) associated with breast cancer 1 ,2 . The case – filed against the three co-owners of the...
A contentious report by the US government’s trade watchdog that reviews its trading partners’ intellectual property rights protection policies appears to tread more softly in its demands than it has...
European Court of Justice advocate general Yves Bot has sought to offer clarification for the granting of supplementary protection certificates in European Union accession countries 1 ,2 . In his...
US biotech companies are worried that recommendations of a government task force on gene patenting and licensing, if implemented, could restrict the ability to obtain, or undermine the enforceability...
The US Senate Judiciary Committee has voted in favour of legislation that aims to put an end to anticompetitive “pay-for-delay” deals between brand-name and generic pharmaceutical companies 1 ,2...
European companies operating in China remain concerned that confidential data submitted by them during patent filing, product registration and other stages of business development are leaked to their...
The US Patent and Trade Mark Office has withdrawn controversial rules issued by the previous administration that sought to limit the size of patent applications 1 . The rules were published in a...
Member states of the World Intellectual Property Organization have agreed to streamline and simplify the existing international registration system for industrial designs from 2010 1 ,2 . The Hague...
Patent offices around the world have agreed to work more closely together to address the problem of backlogs in patent applications. According to World Intellectual Property Organization director...
An Indian court has ruled that it is not unlawful for the country��s drug regulatory agency to consider granting a marketing licence for a generic version of a drug whose patent is still valid 1...
The US Food and Drug Administration has amended its regulations to make it mandatory, from 25 January 2010, for brand-name pharmaceutical companies to provide certain information on authorised...
The Canadian Federal Court has upheld the government’s enactment of data protection regulations that provide up to eight years of protection for innovative drugs and the possibility of a further six...
A petition challenging a US federal appeals court’s test criteria for what types of inventions are considered “patentable processes” has drawn considerable support from the life sciences industry 1...
Poland’s Ministry of Health has drafted a new pharmaceutical law, which is under public discussion until 18 August 1 .The most important difference in comparison to an earlier draft 2 issued last...
